PMID- 25156590 OWN - NLM STAT- MEDLINE DCOM- 20160503 LR - 20231110 IS - 2192-2659 (Electronic) IS - 2192-2640 (Print) IS - 2192-2640 (Linking) VI - 4 IP - 3 DP - 2015 Feb 18 TI - Monocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosis. PG - 367-76 LID - 10.1002/adhm.201400336 [doi] AB - Atherosclerosis is a multifactorial inflammatory disease that can progress silently for decades and result in myocardial infarction, stroke, and death. Diagnostic imaging technologies have made great strides to define the degree of atherosclerotic plaque burden through the severity of arterial stenosis. However, current technologies cannot differentiate more lethal "vulnerable plaques," and are not sensitive enough for preventive medicine. Imaging early molecular markers and quantifying the extent of disease progression continues to be a major challenge in the field. To this end, monocyte-targeting, peptide amphiphile micelles (PAMs) are engineered through the incorporation of the chemokine receptor CCR2-binding motif of monocyte chemoattractant protein-1 (MCP-1) and MCP-1 PAMs are evaluated preclinically as diagnostic tools for atherosclerosis. Monocyte-targeting is desirable as the influx of monocytes is a marker of early lesions, accumulation of monocytes is linked to atherosclerosis progression, and rupture-prone plaques have higher numbers of monocytes. MCP-1 PAMs bind to monocytes in vitro, and MCP-1 PAMs detect and discriminate between early- and late-stage atherosclerotic aortas. Moreover, MCP-1 PAMs are found to be eliminated via renal clearance and the mononuclear phagocyte system (MPS) without adverse side effects. Thus, MCP-1 PAMs are a promising new class of diagnostic agents capable of monitoring the progression of atherosclerosis. CI - (c) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. FAU - Chung, Eun Ji AU - Chung EJ AD - Institute for Molecular Engineering, University of Chicago, 5747 S. Ellis Ave, Chicago, IL, 60637, USA. FAU - Mlinar, Laurie B AU - Mlinar LB FAU - Nord, Kathryn AU - Nord K FAU - Sugimoto, Matthew J AU - Sugimoto MJ FAU - Wonder, Emily AU - Wonder E FAU - Alenghat, Francis J AU - Alenghat FJ FAU - Fang, Yun AU - Fang Y FAU - Tirrell, Matthew AU - Tirrell M LA - eng GR - K08 HL116600/HL/NHLBI NIH HHS/United States GR - R00 HL103789/HL/NHLBI NIH HHS/United States GR - UL1 TR000430/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20140822 PL - Germany TA - Adv Healthc Mater JT - Advanced healthcare materials JID - 101581613 RN - 0 (Apolipoproteins E) RN - 0 (Ccl2 protein, mouse) RN - 0 (Ccr2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Micelles) RN - 0 (Receptors, CCR2) RN - 0 (Recombinant Proteins) SB - IM MH - Amino Acid Sequence MH - Animals MH - Apolipoproteins E/genetics MH - Atherosclerosis/*diagnosis/metabolism/pathology MH - Binding Sites MH - Chemokine CCL2/chemistry/*metabolism/pharmacokinetics MH - Drug Evaluation, Preclinical/methods MH - Female MH - Macrophages MH - Mice, Transgenic MH - Micelles MH - Molecular Sequence Data MH - Monocytes/*metabolism MH - Pathology, Molecular/methods MH - Receptors, CCR2/metabolism MH - Recombinant Proteins/genetics/metabolism/pharmacokinetics MH - Tissue Distribution PMC - PMC4336846 MID - NIHMS632144 OTO - NOTNLM OT - atherosclerosis OT - molecular imaging OT - peptide amphiphiles OT - self-assembly OT - targeting EDAT- 2014/08/27 06:00 MHDA- 2016/05/04 06:00 PMCR- 2015/02/24 CRDT- 2014/08/27 06:00 PHST- 2014/06/17 00:00 [received] PHST- 2014/07/18 00:00 [revised] PHST- 2014/08/27 06:00 [entrez] PHST- 2014/08/27 06:00 [pubmed] PHST- 2016/05/04 06:00 [medline] PHST- 2015/02/24 00:00 [pmc-release] AID - 10.1002/adhm.201400336 [doi] PST - ppublish SO - Adv Healthc Mater. 2015 Feb 18;4(3):367-76. doi: 10.1002/adhm.201400336. Epub 2014 Aug 22.